Display Settings:

Format

Send to:

Choose Destination
    J Infect Dis. 2007 Mar 15;195(6):833-6. Epub 2007 Jan 30.

    Stability of the latent reservoir for HIV-1 in patients receiving valproic acid.

    Source

    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. rsiliciano@jhmi.edu

    Abstract

    In light of a recent report that short-term treatment with valproic acid (VA) might accelerate the decay of the latent reservoir for HIV-1 in patients receiving combination therapy and allow eventual eradication of the infection, we studied patients with prolonged suppression of viremia who were receiving combination therapy and who had also been receiving chronic VA therapy for neurological or psychiatric conditions. Latently infected cells were readily detected in all patients at levels comparable to those seen in patients receiving combination therapy alone. We conclude that the clinical use of VA has no ancillary effect on the decay of the latent reservoir.

    PMID:
    17299713
    [PubMed - indexed for MEDLINE]
    Free full text

      Supplemental Content

      Icon for HighWire Press

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk